If the review concentrates on better results for patients, it could be a positive for CAJ.
Instead of a knee arthroscopy to examine the knee internally, a scan may be used to give as much information as possible in a non-invasive manner.
Similarly for a colonoscopy.
Imaging technology is advancing and giving greater opportunity to give information to specialists in a non-invasive manner.
I am more confident now that this review will concentrate on the medical effectiveness of procedures, rather than simply trying to cut costs.
Medicare review, page-2
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $311.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.3¢ | $1.047M | 3.534M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 588042 | 7 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |